Blue Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Blue Trust's VRTX Position: Q3 2026 in Review
Blue Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 8.6% in Q3 2026, selling an estimated $73.7K and leaving 1,533 shares worth $801K. The position accounts for 0.01% of the portfolio, ranked #346.
Blue Trust first reported a position in VRTX in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.27M in Q3 2024. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Blue Trust held 1,533 shares of Vertex Pharmaceuticals worth $801K as of Q3 2026.
- Blue Trust sold 144 Vertex Pharmaceuticals shares in Q3 2026, an estimated $73.7K.
- Vertex Pharmaceuticals made up 0.01% of Blue Trust's portfolio in Q3 2026, its #346 holding.
- Blue Trust first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Vertex Pharmaceuticals position peaked at $1.27M in Q3 2024.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.